Vancomycin-resistant enterococci: Prevalence and factors associated with intestinal colonization in oncology patients from Hospital de Niños de Córdoba;Enterococos resistentes a vancomicina: Prevalencia y factores asociados a la colonización intestinal en pacientes oncológicos del Hospital de Niños de Córdoba

Revista Argentina de Microbiologia

Volumn 41, Issue 2, 2009, Pages 92-96

  Reale, A L ^a   Depetri, M L ^a   Culasso, C ^a   Paviolo, M ^a   Cheguirian M L ^a   Enrico, M C ^a   Ledesma, E M ^a   Vidal, C ^a   Glatstein, E ^a   Bertoni, L ^a  

^a Hospital de Ninos de la Santisima Trinidad   (Argentina)

Author keywords

Colonization; Oncology patients; Vancomycin resistant enterococci

Indexed keywords

AMPICILLIN; CEFTAZIDIME; CHLORAMPHENICOL; CIPROFLOXACIN; CORTICOSTEROID; GENTAMICIN; LINEZOLID; MEROPENEM; METRONIDAZOLE; MINOCYCLINE; RIFAMPICIN; STREPTOMYCIN; TEICOPLANIN; TETRACYCLINE; TIGECYCLINE; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADOLESCENT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARGENTINA; ARTICLE; BACTERIAL COLONIZATION; CANCER PATIENT; CHILD; ENTEROCOCCAL INFECTION; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; FEMALE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INFANT; INTESTINE; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; PRESCHOOL CHILD; PREVALENCE; PROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD; VANCOMYCIN RESISTANT ENTEROCOCCUS; CROSS INFECTION; DRUG EFFECT; ENTEROCOCCUS; GRAM POSITIVE INFECTION; HOSPITAL; IMMUNE DEFICIENCY; ISOLATION AND PURIFICATION; MICROBIOLOGY; MULTIDRUG RESISTANCE; NEOPLASM; NEWBORN;

ADOLESCENT; ANTI-BACTERIAL AGENTS; ARGENTINA; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROCOCCUS; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HOSPITALS, PEDIATRIC; HUMANS; IMMUNOCOMPROMISED HOST; INFANT; INFANT, NEWBORN; INTESTINES; MALE; NEOPLASMS; NEUTROPENIA; PREVALENCE; RISK FACTORS; VANCOMYCIN RESISTANCE;

EID: 69449088302     PISSN: 03257541     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Avaro A, Egea M, Sola C, Muñoz V, Barbon S, Bocco JL, et al. Colonización intestinal con Enterococcus faecium vancomicina resistentes (EfmVR). XVII Congreso Latinoamericano de Microbiología. X Congreso Argentino de Microbiología, 2004, Resumen A64, Ciudad Autónoma de Buenos Aires, Argentina.
2. Campos Furtado GH, Martins ST, Machado AM, Wey SB, Medeiros EA. Prevalence and factors associated with rectal vancomycin-resistant enterococci colonization in two intensive care units in Sao Paulo, Brazil. Braz J Infect Dis 2005; 9: 1.
3. Cetinkaya Y., Falk P., Mayhall C. Vancomycin resistant Enterococci. Clin Microbiol Rev 2000; 13: 686-707.
4. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial disk and dilution susceptibility testing; 16th informational supplement, 2006; M100-S18. Wayne, Pa, USA.
5. Corso A, Faccone D, Gagetti P, Togneri A, Lopardo H, Melano R, et al. First report of VanA Enterococcus gallinarum dissemination within an intensive care unit in Argentina. Int J Antimicrob Agents 2005; 25: 51-56
6. Elting LS, Rubenstein EB, Rolston KVI, Bodey GP. Outcome of bacteremia in patients with cancer and neutropenia: observations from two decades of epidemiological and clinical trials. Clin Infect Dis 1997; 25: 247-259
7. Facklam RR, Sahm DF, Teixeira LM, Enterococcus. En: Murray PR, Baron EJ, Pfaller MA, editors. Manual of Clinical Microbiology. Washington, D. C., ASM Press, 1999, p. 297-305.
8. Henning KJ, De Lencastre H, Eagan J, Boone N, Brown A, Chung M, et al. Vancomycin-resistant Enterococcus faecium on a pediatric oncology ward: duration of stool shedding and incidence of clinical infection. Pediatr infect Dis J 1996; 15: 848-854
9. Husni R, Hachem R, Hanna H, Raad I. Risk factors for vancomycim-resistant Enterococcus (VRE) infection in colonized patients with cancer. Infect Control Hosp Epidemiol 2002; 23: 102-103 (Pubitemid 34205644)
10. Matar MJ, Tarrand J, Raad I, Rolston KV. Colonization and infection with vancomycin-resistant Enterococcus among patients with cancer. Am J Infect Control 2006; 34: 534-536 (Pubitemid 44479799)
11. Nourse C, Murphy H, Byrne C, O'Meara A, Breatnach F, Kaufmann M, et al. Control of a nosocomial outbreak of vancomycin resistant Enterococcus faecium in a pediatric oncology unit: risk factors for colonization. Eur J Pediatric 1998; 157: 20-27
12. Reid KC, Cockerill IF, Patel R. Clinical and Epidemiological features of Enteroccocus casseliflavus/flavescens and Enterococcus gallinarum bacteremia: a report of 20 cases. Clin Infect. Dis 2001; 32: 1540-1546
13. Suntharam N, Lankford MG, Trick WE, Peterson LR, Noskin GA. Risk factors for acquisition of vancomycin-resistant enterococci among hematology-oncology patients. Diagn Microbiol Infect Dis 2002; 43: 183-188 (Pubitemid 34775071)
14. Togneri AM, Corso A, González J, Lopardo H, Podestá LB, Gagetti P et al. Análisis clínico-epidemiológico de la portación intestinal de enterococos resistentes a vancomicina en una unidad de terapia intensiva. Rev Argent Microbiol 2005; 37: 26-33. (Pubitemid 40896677)
15. Van den Braak N, Van Belkun A, Van Keuleum M, Vliegendhart J. Prevalence and determinants of fecal colonization with vancomycin resistant Enterococcus in hospitalizad patients in The Netherlands. Infect Control Hosp Epidemiol 2000; 21: 520-524 (Pubitemid 30647156)